Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Monoclonal Gammopathy with Secondary Atypical Hemolytic-Uremic Syndrome

Trisha Kissoon, MD MBA, Sudha Mannemuddhu, MD, Mansi Dalal, MD, Lawrence Shoemaker, MD

Blood (2019) 134 (Supplement_1): 5465.

https://doi.org/10.1182/blood-2019-131826

Published: 2019

Journal Articles

A Proteomic Atlas of Cardiac Amyloidosis

Taxiarchis Kourelis, MD, Surendra Dasari, PhD, Ahmed U Fayyaz, MD, Martha Grogan, Marina Ramirez-Alvarado, Margaret Redfield, Omar F. abou Ezzeddine, MD, C.M., M.S., Angela Dispenzieri, MD, Ellen D. McPhail, MD

Blood (2019) 134 (Supplement_1): 1790.

https://doi.org/10.1182/blood-2019-124802

Published: 2019

Journal Articles

An Alternative Pathway Specific Flow Cytometric Assay to Detect Complement Activation in Atypical Hemolytic Uremic Syndrome (aHUS)

Jia Yu, Xuan Yuan, MD MSc, Kang Zhou, Daniel White, Samuel A. Merrill, MD PhD, Robert A. Brodsky, MD

Blood (2018) 132 (Supplement 1): 3748.

https://doi.org/10.1182/blood-2018-99-119445

Published: 2018

Journal Articles

Pre-Transplant Genetic Susceptibility in Adult Allogeneic Hematopoietic Cell Transplant Recipients: Incidence and Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy

Blood (2018) 132 (Supplement 1): 3401.

https://doi.org/10.1182/blood-2018-99-112041

Published: 2018

Journal Articles

Complement-Mediated Thrombotic Microangiopathy: A Murky Presentation of a Rare Disease Entity

Patrick Fleming, MD, Maggie Cheung, MD, David Sokol, MD

Blood (2018) 132 (Supplement 1): 5005.

https://doi.org/10.1182/blood-2018-99-119893

Published: 2018

Journal Articles

Effective Treatment of Thrombotic Microangiopathy Associated with Lupus Nephritis with Eculizumab: a Series of 8 Cases

Mihee Park, MD BS, Ilene Ceil Weitz, MD

Blood (2017) 130 (Supplement 1): 1043.

https://doi.org/10.1182/blood.V130.Suppl_1.1043.1043

Published: 2017

Journal Articles

Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation

Yoshiyasu Ueda, Imran Mohammed, Delu Song, Damodar Gullipalli, Lin Zhou, Sayaka Sato, Yuan Wang, Shuchi Gupta, Zhongjian Cheng, Hong Wang, Jialing Bao, Yingying Mao, Lawrence Brass, X. Long Zheng, Takashi Miwa, Matthew Palmer, Joshua Dunaief, Wen-Chao Song

Blood (2017) 129 (9): 1184–1196.

https://doi.org/10.1182/blood-2016-07-728253

Published: 2017

Includes: Supplemental data

Journal Articles

Laboratory-Developed MLPA ® Probes Enable CNV Detection in the CFHR4 Gene to Aid aHUS Genetic Evaluation

Kevin Pirelli, BS, Curt Czajkowski, BS, MT(ASCP), Veronika Mladenova, BS, Stefanie Dugan, MS, CGC, Valerie Trapp-Stamborski, PhD, Kenneth D Friedman, MD, Rupa A Udani, PhD

Blood (2016) 128 (22): 1361.

https://doi.org/10.1182/blood.V128.22.1361.1361

Published: 2016

Journal Articles

Three Cases of Patients with Complement Regulatory Factor Genetic Mutations and Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Shebli Atrash, MD, David Kent McKelvey, MD, Appalanaidu Sasapu, MD MS, Muthu Veeraputhiran, MD MPH, Soumya Pandey, MD, Michele H. Cottler-Fox, MD, Pooja Motwani, MD

Blood (2016) 128 (22): 1362.

https://doi.org/10.1182/blood.V128.22.1362.1362

Published: 2016

Journal Articles

β-2-Glycoprotein Antibodies Activate the Alternative Pathway of Complement in Antiphospholipid Antibody Syndrome

Andrea C. Baines, MD PhD, Xuan Yuan, MD MSc, Eleni Gavriilaki, MD PhD, Alexander J. Ambinder, MD MPH, Alka Jain, PhD, Neal S. Fedarko, PhD, C. John Sperati, MD MHS, Alison R. Moliterno, MD, Rakhi P. Naik, MD MHS, Michael Streiff, MD, Wei Fu, MS, Michelle Petri, MD MPH, Robert A. Brodsky, MD

Blood (2016) 128 (22): 3818.

https://doi.org/10.1182/blood.V128.22.3818.3818

Published: 2016

Journal Articles

Inhibition of Alternative Complement Pathway in Target Organs Represents a Novel and Effective Approach to Control Gvhd While Sparing GVL Effect

Hung D Nguyen, PhD, Ali Alawieh, MD PhDCandidate, David A Bastian, BS, Anusara Daenthanasanmak, PhD, Steven D Schutt, BS, Supinya Iamsawat, MSc, Yongxia Wu, PhD, Atkinson Carl, PhD, Stephen Tomlinson, PhD, Xue-Zhong Yu, PhD

Blood (2016) 128 (22): 807.

https://doi.org/10.1182/blood.V128.22.807.807

Published: 2016

Journal Articles

Crucial Role of Complement Activation and IL-1β in Bone Marrow Niche of Immune Thrombocytopenia

Xiao-Lu Zhu, Jia-Min Zhang, Qian-Ming Wang, Hai-Xia Fu, Meng Lv, Yuan Kong, Ying-Jun Chang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2016) 128 (22): 166.

https://doi.org/10.1182/blood.V128.22.166.166

Published: 2016

Journal Articles

Sweeteners for factor H

Edward M. Conway

Blood (2016) 127 (22): 2656–2658.

https://doi.org/10.1182/blood-2016-04-708172

Published: 2016

Journal Articles

Modified Ham Test Distinguishes aHUS from TTP and Predicts Response to Eculizumab

Eleni Gavriilaki, MD, Xuan Yuan, MD MSc, Zhaohui Ye, PhD, Michael B. Streiff, MD, Thomas S Kickler, MD, Alison R Moliterno, MD, John Sperati, MD, Robert A. Brodsky, MD

Blood (2015) 126 (23): 103.

https://doi.org/10.1182/blood.V126.23.103.103

Published: 2015

Journal Articles

Novel Genetic Variants in Complement-Mediated Thrombotic Microangiopath

Blood (2015) 126 (23): 1050.

https://doi.org/10.1182/blood.V126.23.1050.1050

Published: 2015

Journal Articles

A Novel Case of Direct Antiglobulin Test-Negative Intravascular Hemolysis in a Patient with Smoldering Myeloma

Selina Dobing, MD BSc, Nikolas Desilet, MD BSc, Irwindeep Sandhu, MD, Lauren Bolster, MD MD FRCPC

Blood (2015) 126 (23): 4539.

https://doi.org/10.1182/blood.V126.23.4539.4539

Published: 2015

Journal Articles

Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Pediatric and Adult Patients with or without Identified Genetic Complement Mutations or Complement Factor H Autoantibodies

Spero R Cataland, MD, Thorsten Feldkamp, MD, Camille L. Bedrosian, MD, John Kincaid, MD MA, Enrico E. Minetti, MD

Blood (2014) 124 (21): 2789.

https://doi.org/10.1182/blood.V124.21.2789.2789

Published: 2014

Journal Articles

Utility of Complement and ADAMTS13 Testing in Diagnosis of Thrombotic Microangiopathy: A Single Centre Retrospective Review

Katerina Pavenski, MD FRCP, Christoph Licht, MD, Michael Kirschfink

Blood (2014) 124 (21): 2787.

https://doi.org/10.1182/blood.V124.21.2787.2787

Published: 2014

Journal Articles

Successful Eculizumab Therapy in Thrombotic Thrombocytopenic Purpura (TTP) Refractory to Plasma Exchange, Steroids and Rituximab

Harjot Kaur, MD, Appalanaidu Sasapu, MD MS, Michele H Fox, MD, Pooja Motwani, MD

Blood (2014) 124 (21): 2794.

https://doi.org/10.1182/blood.V124.21.2794.2794

Published: 2014

Journal Articles

Genotype Phenotype Correlation in Patients with aHUS and Abnormal Genetic Studies: A Single Centre Experience

Katerina Pavenski, MD FRCP, Jerome M. Teitel, MD, Gloria Lim, BSc, MSc, MD, Michelle Sholzberg, MD, Michael Kirschfink, Christoph Licht, MD FRCP(C), FASN

Blood (2014) 124 (21): 4186.

https://doi.org/10.1182/blood.V124.21.4186.4186

Published: 2014

NARROW

Monoclonal Gammopathy with Secondary Atypical Hemolytic-Uremic Syndrome

A Proteomic Atlas of Cardiac Amyloidosis

An Alternative Pathway Specific Flow Cytometric Assay to Detect Complement Activation in Atypical Hemolytic Uremic Syndrome (aHUS)

Pre-Transplant Genetic Susceptibility in Adult Allogeneic Hematopoietic Cell Transplant Recipients: Incidence and Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy

Complement-Mediated Thrombotic Microangiopathy: A Murky Presentation of a Rare Disease Entity

Effective Treatment of Thrombotic Microangiopathy Associated with Lupus Nephritis with Eculizumab: a Series of 8 Cases

Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation

Laboratory-Developed MLPA ® Probes Enable CNV Detection in the CFHR4 Gene to Aid aHUS Genetic Evaluation

Three Cases of Patients with Complement Regulatory Factor Genetic Mutations and Acquired Thrombotic Thrombocytopenic Purpura (TTP)

β-2-Glycoprotein Antibodies Activate the Alternative Pathway of Complement in Antiphospholipid Antibody Syndrome

Inhibition of Alternative Complement Pathway in Target Organs Represents a Novel and Effective Approach to Control Gvhd While Sparing GVL Effect

Crucial Role of Complement Activation and IL-1β in Bone Marrow Niche of Immune Thrombocytopenia

Sweeteners for factor H

Modified Ham Test Distinguishes aHUS from TTP and Predicts Response to Eculizumab

Novel Genetic Variants in Complement-Mediated Thrombotic Microangiopath

A Novel Case of Direct Antiglobulin Test-Negative Intravascular Hemolysis in a Patient with Smoldering Myeloma

Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Pediatric and Adult Patients with or without Identified Genetic Complement Mutations or Complement Factor H Autoantibodies

Utility of Complement and ADAMTS13 Testing in Diagnosis of Thrombotic Microangiopathy: A Single Centre Retrospective Review

Successful Eculizumab Therapy in Thrombotic Thrombocytopenic Purpura (TTP) Refractory to Plasma Exchange, Steroids and Rituximab

Genotype Phenotype Correlation in Patients with aHUS and Abnormal Genetic Studies: A Single Centre Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only